Market revenue in 2023 | USD 1,707.1 million |
Market revenue in 2030 | USD 2,436.2 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Dracunculiasis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.89% in 2023. Horizon Databook has segmented the Middle East & Africa neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region covers South Africa and other countries, including UAE, Nigeria, Ghana, Zimbabwe, & Saudi Arabia. Presence of high untapped opportunities and improvement in healthcare facilities over the last few years in underdeveloped countries of MEA are expected to propel market growth in MEA.
In addition, increase in the number of diagnostic manufacturers in countries, such as South Africa and Saudi Arabia, is projected to accelerate growth of neglected tropical diseases diagnosis market.
The market in this region is driven by high incidence of NTDs, rise in consumer awareness, and improvements in healthcare infrastructure.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa neglected tropical diseases diagnosis market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account